Powered by

ProMetic Enters Into $1.6 Million Development Agreement With New Client

Feb 06, 2014 - Marketwired

LAVAL, QUEBEC--(Marketwired - Feb. 6, 2014) - ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF), ("ProMetic" or the "Corporation") announced today that its UK based subsidiary, ProMetic BioSciences Ltd. ("PBL"), has entered into a new agreement with a leading vaccines company, for the development of an affinity adsorbent and associated purification process for the production of a novel vaccine product.

Under this new Agreement, PBL will use its ligand design and screening capabil...